These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2045531)

  • 21. Cyclosporin A-treated guinea pig responder cells secrete a genetically restricted factor that suppresses the mixed leukocyte reaction.
    DosReis GA; Shevach EM
    J Clin Invest; 1983 Jan; 71(1):165-9. PubMed ID: 6600235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors.
    Kabelitz D; Zanker B; Zanker C; Heeg K; Wagner H
    Immunology; 1987 May; 61(1):57-62. PubMed ID: 3108142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance.
    Copeland KR; Yatscoff RW; McKenna RM
    Clin Chem; 1990 Feb; 36(2):225-9. PubMed ID: 2137384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity of cyclosporine metabolites.
    Copeland KR; Thliveris JA; Yatscoff RW
    Ther Drug Monit; 1990 Nov; 12(6):525-32. PubMed ID: 2274998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
    Hess AD; Tutschka PJ; Santos GW
    J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells.
    Rosoff PM; Terres G
    J Cell Biol; 1986 Aug; 103(2):457-63. PubMed ID: 3015982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity.
    Liu J; Albers MW; Wandless TJ; Luan S; Alberg DG; Belshaw PJ; Cohen P; MacKintosh C; Klee CB; Schreiber SL
    Biochemistry; 1992 Apr; 31(16):3896-901. PubMed ID: 1373650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
    Sadeg N; Pham-Huy C; Rucay P; Righenzi S; Halle-Pannenko O; Claude JR; Bismuth H; Duc HT
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):163-77. PubMed ID: 8349948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.
    Rosano TG; Freed BM; Cerilli J; Lempert N
    Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells.
    Bejarano MT; Masucci MG; Ernberg I; Klein E; Klein G
    Int J Cancer; 1985 Mar; 35(3):327-33. PubMed ID: 2982748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine.
    Orosz CG; Roopenian DC; Widmer MB; Bach FH
    Transplantation; 1983 Dec; 36(6):706-11. PubMed ID: 6229074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.
    Loor F; Tiberghien F; Wenandy T; Didier A; Traber R
    J Med Chem; 2002 Oct; 45(21):4613-28. PubMed ID: 12361388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of alloantigen presentation by cyclosporine.
    Little RG; Ebertowski LA; David CS
    Transplantation; 1990 May; 49(5):937-44. PubMed ID: 2159662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporine and the immune response: basic aspects.
    Hess AD; Colombani PM; Esa AH
    Crit Rev Immunol; 1986; 6(2):123-49. PubMed ID: 2942335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine A on human T lymphocyte alloproliferative response in vitro.
    Schanz U; Hügle T; Gmür J
    Transplantation; 1996 Jun; 61(12):1736-40. PubMed ID: 8685953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes.
    Rampino T; Ranghino A; Guidetti C; Gregorini M; Soccio G; Marasà M; Libetta C; Guida G; De Amici M; Dal Canton A
    Transpl Immunol; 2007 Jul; 18(1):32-6. PubMed ID: 17584600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cyclosporine on interleukin 2 receptor expression in a human alloreactive T cell clone.
    Chabannes D; Le Mauff B; Hallet MM; Yacques Y; Soulillou JP
    Transplantation; 1988 Aug; 46(2 Suppl):97S-100S. PubMed ID: 3136569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of influence of cyclosporine on antigen presentation to lysozyme-specific T cell hybridomas.
    Muller S; Adorini L; Appella E; Nagy ZA
    Transplantation; 1988 Aug; 46(2 Suppl):44S-48S. PubMed ID: 3261467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of alloresponsive naive and memory T cells by CD7 and CD25 antibodies and by cyclosporine.
    Akbar AN; Amlot PL; Ivory K; Timms A; Janossy G
    Transplantation; 1990 Nov; 50(5):823-9. PubMed ID: 1700506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.